Figure 2
Figure 2. How I treat AdV in HSCT recipients: treatment guideline. Refer to the text for a detailed explanation. Lympho. Prolif. Inh. Indicates lymphocyte proliferation inhibitor (eg, cyclosporin A, CsA); *alternative cidofovir 5 mg/kg intravenously weekly. **For centers that have the AdV CTLs readily available, CTLs are immediately initiated for all high-risk patients and for all patients with AdV symptoms before awaiting cidofovir effect.

How I treat AdV in HSCT recipients: treatment guideline. Refer to the text for a detailed explanation. Lympho. Prolif. Inh. Indicates lymphocyte proliferation inhibitor (eg, cyclosporin A, CsA); *alternative cidofovir 5 mg/kg intravenously weekly. **For centers that have the AdV CTLs readily available, CTLs are immediately initiated for all high-risk patients and for all patients with AdV symptoms before awaiting cidofovir effect.

Close Modal

or Create an Account

Close Modal
Close Modal